These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23065913)

  • 21. Validation of a novel immunoassay for the detection of synthetic cannabinoids and metabolites in urine specimens.
    Arntson A; Ofsa B; Lancaster D; Simon JR; McMullin M; Logan B
    J Anal Toxicol; 2013 Jun; 37(5):284-90. PubMed ID: 23625703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of adulterants on urine screen for drugs of abuse: detection by an on-site dipstick device.
    Wong R
    Am Clin Lab; 2002; 21(1):37-9. PubMed ID: 11975450
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical Interpretation of Urine Drug Tests: What Clinicians Need to Know About Urine Drug Screens.
    Moeller KE; Kissack JC; Atayee RS; Lee KC
    Mayo Clin Proc; 2017 May; 92(5):774-796. PubMed ID: 28325505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An evaluation of the diagnostic accuracy of liquid chromatography-tandem mass spectrometry versus immunoassay drug testing in pain patients.
    Pesce A; Rosenthal M; West R; West C; Crews B; Mikel C; Almazan P; Latyshev S
    Pain Physician; 2010; 13(3):273-81. PubMed ID: 20495592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urine drug testing for social service agencies. A Canadian experience.
    Fraser AD
    Clin Lab Med; 1998 Dec; 18(4):705-11. PubMed ID: 9891609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug screening in urine by cloned enzyme donor immunoassay (CEDIA) and kinetic interaction of microparticles in solution (KIMS): a comparative study.
    Schwettmann L; Külpmann WR; Vidal C
    Clin Chem Lab Med; 2006; 44(4):479-87. PubMed ID: 16599844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Workplace drug testing in Italy: findings about second-stage testing.
    Vignali C; Stramesi C; Morini L; San Bartolomeo P; Groppi A
    Drug Test Anal; 2015 Mar; 7(3):173-7. PubMed ID: 24652693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association of pseudoephedrine sales restrictions on emergency department urine drug screen results in Oklahoma.
    Brandenburg MA; Brown SJ; Arneson WL; Arneson DL
    J Okla State Med Assoc; 2007 Nov; 100(11):436-9. PubMed ID: 18183861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determining the effects of adulterants on drug detection via enzyme-linked immunosorbent assay and adulterant tests strips.
    Olivieri B; Marić M; Bridge C
    Drug Test Anal; 2018 Sep; 10(9):1383-1393. PubMed ID: 29749024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A snapshot of workplace drug testing in Italy.
    Santoro PE; De Nardis I; Fronterrè P; Felli M; Martello S; Bergamaschi A; Chiarotti M
    Drug Test Anal; 2012 Feb; 4(2):66-70. PubMed ID: 22362571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Commonly prescribed medications and potential false-positive urine drug screens.
    Brahm NC; Yeager LL; Fox MD; Farmer KC; Palmer TA
    Am J Health Syst Pharm; 2010 Aug; 67(16):1344-50. PubMed ID: 20689123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [On-site testing for drug abuse in urine].
    Espnes KA; Spigset O; Delaveris GJ; Mørland J; Smith-Kielland A
    Tidsskr Nor Laegeforen; 2006 Sep; 126(17):2257-60. PubMed ID: 16967064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of glutaraldehyde (UrinAid) on detection of abused drugs in urine by immunoassay.
    Goldberger BA; Caplan YH
    Clin Chem; 1994 Aug; 40(8):1605-6. PubMed ID: 8045013
    [No Abstract]   [Full Text] [Related]  

  • 34. Workplace drug testing, different matrices different objectives.
    Tsanaclis LM; Wicks JF; Chasin AA
    Drug Test Anal; 2012 Feb; 4(2):83-8. PubMed ID: 22362574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The subversion of urine drug testing.
    Berge KH; Bush DM
    Minn Med; 2010 Aug; 93(8):45-7. PubMed ID: 20862879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lower Cutoffs for LC-MS/MS Urine Drug Testing Indicates Better Patient Compliance.
    Krock K; Pesce A; Ritz D; Thomas R; Cua A; Rogers R; Lipnick P; Kilbourn K
    Pain Physician; 2017 Nov; 20(7):E1107-E1113. PubMed ID: 29149155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. False positives and negatives in routine testing for drugs of abuse.
    Notarianni LJ; Belk D; Collins AJ
    Lancet; 1995 Apr; 345(8957):1115. PubMed ID: 7715360
    [No Abstract]   [Full Text] [Related]  

  • 38. Utility of ELISA screening for the monitoring of abstinence from illegal and legal drugs in hair and urine.
    Agius R; Nadulski T
    Drug Test Anal; 2014 Jun; 6 Suppl 1():101-9. PubMed ID: 24817055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of random drug testing in an adolescent substance abuse program.
    Levy S; Sherritt L; Vaughan BL; Germak M; Knight JR
    Pediatrics; 2007 Apr; 119(4):e843-8. PubMed ID: 17403828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drugs of abuse in urine: some pitfalls in testing.
    Bosomworth MP
    Br J Biomed Sci; 1993 Jun; 50(2):150-5. PubMed ID: 8219920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.